2026 Independent Medical Education Call for Grants supports community primary care physicians through certified education on cognitive health and Alzheimer’s disease to strengthen early detection and diagnosis.
Funder: Roche
Due Dates: October 30, 2026 (Full proposal) | November 10, 2026 (Decision notifications by)
Funding Amounts: Up to $200,000
Summary: Supports independent, certified education helping community primary care physicians address cognitive health and detect Alzheimer’s disease earlier.
Key Information: Applicants must be U.S.-based, accredited CME/CE providers in good standing with a registered gFRS account.
Genentech’s Independent Medical Education team, part of the Roche Group, invites accredited educational providers to develop independent, certified education focused on Alzheimer’s disease and cognitive health. The primary learning audience is community primary care physicians. The call supports education addressing evidence-based gaps in healthcare professionals’ knowledge, competence, and performance to improve patient care.
Educational priorities include patient-centered conversations about brain health, cognitive decline, and dementia risk; systematic assessment of modifiable and nonmodifiable cognitive risk factors; and validated tools that distinguish mild cognitive impairment from normal age-related changes. Programs should also improve understanding of emerging blood-based biomarkers and their potential clinical application in identifying preclinical Alzheimer’s disease pathology. Together, these priorities seek to strengthen early detection and establish primary care as a cornerstone of dementia prevention and early diagnosis.